Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001178913-19-001080)

Filing Details

Accession Number:: 0001178913-19-001080
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-04-08 16:12:01
Reporting Period:: 2019-04-08

Accepted Time:: 2019-04-08 16:12:01
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1158780	Pluristem Therapeutics Inc	PSTI	Biological Products, (No Disgnostic Substances) (2836)	980351734

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1549907	Moria Kwiat	Matam Park, Building #5 Haifa L3 3508409		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-04-08	28,571	$0.70	373,571	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Warrant	Acquisiton	2019-04-08	28,571	$0.00	28,571	$0.70

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
28,571	2019-04-08	2024-04-08	No	4	P	Direct

Footnotes

The common stock and common stock warrant were acquired in the issuer's public underwritten offering of units, in which each unit consisted of one share of commonstock and an accompanying common stock warrant to purchase one share of common stock, at a price of $0.70 per unit. The price paid per unit is reflected in Table I.
The common stock warrants were exercisable immediately upon their issuance.